174 related articles for article (PubMed ID: 32380056)
1. The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker.
Darvishi B; Boroumandieh S; Majidzadeh-A K; Salehi M; Jafari F; Farahmand L
Exp Mol Pathol; 2020 Aug; 115():104443. PubMed ID: 32380056
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.
van Kilsdonk JW; Wilting RH; Bergers M; van Muijen GN; Schalkwijk J; van Kempen LC; Swart GW
Cancer Res; 2008 May; 68(10):3671-9. PubMed ID: 18483249
[TBL] [Abstract][Full Text] [Related]
3. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function.
Ikeda K; Quertermous T
J Biol Chem; 2004 Dec; 279(53):55315-23. PubMed ID: 15496415
[TBL] [Abstract][Full Text] [Related]
4. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
5. CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion.
Kijima N; Hosen N; Kagawa N; Hashimoto N; Nakano A; Fujimoto Y; Kinoshita M; Sugiyama H; Yoshimine T
Neuro Oncol; 2012 Oct; 14(10):1254-64. PubMed ID: 22166264
[TBL] [Abstract][Full Text] [Related]
6. ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression.
Ferragut F; Vachetta VS; Troncoso MF; Rabinovich GA; Elola MT
Cytokine Growth Factor Rev; 2021 Oct; 61():27-37. PubMed ID: 34272152
[TBL] [Abstract][Full Text] [Related]
7. ALCAM/CD166: cancer-related issues.
Weidle UH; Eggle D; Klostermann S; Swart GW
Cancer Genomics Proteomics; 2010; 7(5):231-43. PubMed ID: 20952758
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation.
Ye M; Du YL; Nie YQ; Zhou ZW; Cao J; Li YF
Mol Med Rep; 2015 Mar; 11(3):2004-12. PubMed ID: 25395097
[TBL] [Abstract][Full Text] [Related]
9. Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.
van Kilsdonk JW; Takahashi N; Weidle U; Burtscher H; Jarry J; Daha MR; Swart GW; van Kempen LC
J Invest Dermatol; 2012 May; 132(5):1462-70. PubMed ID: 22318386
[TBL] [Abstract][Full Text] [Related]
10. Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator.
King JA; Ofori-Acquah SF; Stevens T; Al-Mehdi AB; Fodstad O; Jiang WG
Breast Cancer Res; 2004; 6(5):R478-87. PubMed ID: 15318930
[TBL] [Abstract][Full Text] [Related]
11. Activated leukocyte cell adhesion molecule expression and shedding in thyroid tumors.
Miccichè F; Da Riva L; Fabbi M; Pilotti S; Mondellini P; Ferrini S; Canevari S; Pierotti MA; Bongarzone I
PLoS One; 2011 Feb; 6(2):e17141. PubMed ID: 21364949
[TBL] [Abstract][Full Text] [Related]
12. Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis.
van Kempen LC; Meier F; Egeblad M; Kersten-Niessen MJ; Garbe C; Weidle UH; Van Muijen GN; Herlyn M; Bloemers HP; Swart GW
J Invest Dermatol; 2004 May; 122(5):1293-301. PubMed ID: 15140234
[TBL] [Abstract][Full Text] [Related]
13. Activated leukocyte cell-adhesion molecule (ALCAM) promotes malignant phenotypes of malignant mesothelioma.
Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Yokoi K; Osada H; Sekido Y
J Thorac Oncol; 2012 May; 7(5):890-9. PubMed ID: 22722789
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer.
Piao D; Jiang T; Liu G; Wang B; Xu J; Zhu A
Mol Biol Rep; 2012 Jan; 39(1):661-8. PubMed ID: 21670959
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer.
Jeong YJ; Oh HK; Park SH; Bong JG
Molecules; 2018 Jan; 23(1):. PubMed ID: 29315254
[TBL] [Abstract][Full Text] [Related]
16. A novel molecular magnetic resonance imaging agent targeting activated leukocyte cell adhesion molecule as demonstrated in mouse brain metastasis models.
Zarghami N; Soto MS; Perez-Balderas F; Khrapitchev AA; Karali CS; Johanssen VA; Ansorge O; Larkin JR; Sibson NR
J Cereb Blood Flow Metab; 2021 Jul; 41(7):1592-1607. PubMed ID: 33153376
[TBL] [Abstract][Full Text] [Related]
17. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
Jezierska A; Matysiak W; Motyl T
Med Sci Monit; 2006 Aug; 12(8):BR263-73. PubMed ID: 16865058
[TBL] [Abstract][Full Text] [Related]
18. ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients.
Tachezy M; Effenberger K; Zander H; Minner S; Gebauer F; Vashist YK; Sauter G; Pantel K; Izbicki JR; Bockhorn M
Int J Cancer; 2012 Jul; 131(2):396-405. PubMed ID: 21858815
[TBL] [Abstract][Full Text] [Related]
19. Expression of the cell to cell adhesion molecule, ALCAM, in breast cancer patients and the potential link with skeletal metastasis.
Davies SR; Dent C; Watkins G; King JA; Mokbel K; Jiang WG
Oncol Rep; 2008 Feb; 19(2):555-61. PubMed ID: 18202807
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction.
van Kempen LC; Nelissen JM; Degen WG; Torensma R; Weidle UH; Bloemers HP; Figdor CG; Swart GW
J Biol Chem; 2001 Jul; 276(28):25783-90. PubMed ID: 11306570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
